Category Archives: Spotlight Interviews

HAVI Global Solutions: Nick Bullard, Director of Business Analytics & Nikhil Thaker, Director of Business Analytics

Leave a comment

Nick&Nik

Nick Bullard and Nikhil Thaker will discuss how rethinking your optimization strategies can prepare your organization for the challenges that lie ahead. Register here.

 

1. Why did you decide to do a webinar with us?

Nick: At HGS, we take tremendous pride in our Optimization services. We continue to leverage platforms, such as webinars to showcase our capabilities in a way that we can provide new and useful takeaways for our clients, potential clients and industry partners. Webinars are also an excellent vehicle to solicit feedback from other solution owners, while strengthening our professional network across business users and owners.

2. What are you looking forward to discussing with the audience?

Nikhil: We are looking forward to discussing the following with our audience:

  •  Our view on the changing business landscape for companies to anticipate what’s ahead of the curve
  • Our experience in enabling global customers to become leaders in supply chain design and execution
  • Examples of where business agility can be achieved along with cost reduction by using a combination of data analytics and technology
  • How utilizing the right technology can help blend the art and science of supply chain data analytics

3. What do you most enjoy about your role?

Nikhil: Given the various hats I wear in my role, it’s hard to pinpoint a favorite. On the delivery end, I enjoy working with clients who want to make informed decisions to best enable them to serve their customers effectively. On the development side, it’s the utilization of cutting edge technology to solve real world complex business problems and the opportunity to test the hypothesis and solutions in real world. Of course, I look forward to coming into a fun-filled and energetic work environment every day with highly qualified colleagues. The most rewarding part is the fact that I am able to see the immediate impact of solutions as they are executed within client organizations.

Nick: Having worked in Operations Research and Network Optimization roles for more than 10 years now, there is a level of personal satisfaction that goes hand in hand with solving some of the most complex strategic challenges facing businesses today. I’ve always enjoyed blending both analytical, logic-based problem solving tactics with good old-fashioned pragmatic and often intuition-based thinking. It’s the combination of art and science that has allowed me to leverage both logical and creative mindsets. This has given me the opportunity to work with a broad set of experts and in turn, allowed me to continue to learn more about our clients’ businesses and the potential to improve them. Ultimately, the most enjoyable part of my role is leaving something in a much better place than where it started.

4. Where is your favorite place in the world and why?

Nikhil:   My college library. This is the place where within 2 years of my life, I gained tremendous knowledge. Better yet, I was able to derive a way by which I could assimilate information to further my understanding of systems, people, technology and interaction. I try to revisit the library every couple of years, and it is still inspiring every time I am back there.

Nick: La Rambla. It is a centrally located street in downtown Barcelona that is known for its eclectic variety of restaurants, stores, and street performers. In visiting, I found the major tourist corridor was unrivaled in the overall energy and experience of interacting with people from all over the world.

Join Nick & Nikhil in HAVI Global Solutions’ webinar ‘Dynamic Network Optimization‘ on 22nd September. Register here.

 

 

Petr Niedoba, Connected Services Principal, OSIsoft EMEA

Leave a comment

PetrNiedobaPetr Niedoba is the leader of the Connected Services business for OSIsoft in EMEA. Petr has over 18 years experience in the operations and productivity improvements solutions industry. Prior to OSIsoft Petr was at Honeywell Process Solutions as the Advanced Solutions Consulting Manager for EMEA, providing consultancy for numerous processing industry organisation to help them improve their operations and maintenance processes and procedures!

 

1. What are you looking forward to discussing with the audience?

The topic of the meeting is Connected Services, those can be defined as any services based on the customer operating data, with the purpose of bringing them added value. Some business examples include performance monitoring of the process or critical assets, predictive maintenance, fleet monitoring, facility management and many others – Connected Services are still developing and the opportunities seem to be endless. I want to discuss what added value the Connected Services bring to all stakeholders, share our experience and business cases from our customer community . We have sponsored a market research on the acceptance of Connected Services and the drivers for the asset owners to share data with their vendors and I will show the results. I would also like to hear how the companies in different industries are doing in this field – any positive or negative experience will be worth for the audience. For instance, many companies have already started to develop some Connected Services using in-house developed systems, but as their business grows they often see the system performance is not sufficient, the solutions are not scalable and the support is slow, or they need to unify various systems used by different departments.

2. Why did you decide to do a webinar with us?

OSIsoft has been a leader in providing the PI System for real time data collection and analysis to processing industries and power generation companies. 65% of fortune 500 companies use our system to collect the time series data from various sources to have one view on the truth and to feed the data to other systems such as ERP, CMMS or BI. We see now a growing demand to use such systems not only to share the data inside the company, but also with other parties – service vendors, critical equipment vendors, JV members or partners. We wanted to talk about our experience and hear from the other parties on how the operating data can be used outside of the companies who generate them. We believe the webinar is a good means of establishing the communication.

3. What do you most enjoy about your role?

If I should use just one word, it would be – versatility. With the IIoT “hype” it is progressively easier to add sensors to any equipment. Machines can generate more data than ever and companies are looking at new ways of creating value for their customers by using them. With all of that, we are amazed about how many different new Connected Services are being developed every day, and I am excited to be a part of it.

4. What has been the highlight of your career?

At the previous employer I was awarded the President’s Club, a very prestigious recognition that also included a trip to Florida for a couple of days where the winner can choose to undertake  some interesting activities . I chose deep sea fishing and I was very much looking forward to spending a day in a boat to catch big fish like the Hemingway’s Old Man Santiago, but in fact I spent all day just throwing up over the board.

5. Where is your favourite place in the world and why?

Anywhere on the saddle of my mountain bike or on my skis. But honestly, due to the extent of my business travel, I mostly enjoy being around my home with the beautiful landscape of the Berounka river valley near Prague.

Petr will be presenting the OSIsoft webinar ‘Connected Services: New Revenue Opportunities for Equipment Vendors and Remote Service Providers‘ on the 23rd September. Register here.

Michelle Frisch MBA, Sr. Manager, Global Technical Systems, Powder Systems Limited

Leave a comment

mich

Michelle Frisch holds two Bachelor of Science degrees, and also maintains a Technical Education Teaching Certificate. She also has completed her Masters in Business Administration. She is a member of the prestigious “Golden Key National Honor Society”.

Michelle worked for Boise State University as a program manager, in conjunction with OHSA, establishing/developing OSHA compliance and writing operational/training manuals for external corporations. Along with this she developed risk assessment training for blood born pathogens and high risk environmental exposure.

Michelle has been working with the pharmaceutical industry for over 18 years, specializing in high containment technologies with Powder Systems Limited (PSL), establishing PSL USA in 1997. She is a member of the American Institute of Chemical Engineers, American Industrial Hygiene Association, AAPS, SBE, ISPE, and is on the Standards Committee for the American Glovebox Society. Michelle has also served on the subcommittee for COP for ISPE.

1. Why did you decide to do a webinar with Business Review Webinars?

Handling bio hazardous materials today poses more adverse complications to operators than in years past. Being able to handle these infectious materials is critical in the development for cures.

PSL believes that working with Business Review Webinars is the best way to approach the right people and share our knowledge in an effective manner. The webinar format supplies by Business Review allows drug manufacturers around the world to come together and gain key understandings for their process.

2. What will the audience gain from attending your webinar? 

There is a cross over in equipment with bio hazardous materials that provides more stringent operator protection and meets decontamination requirements. The audience will learn the differences between Class III Biosafety Cabinets and High Containment Glovebox, but more so how the latter can provide better control of their process.

3. What’s your favourite thing about presenting to a live audience?

When presenting to a live audience I like the interaction with the audience. The Q&A session at the end of a presentation is a good opportunity to discuss further some specifics following a generic subject. With Business Review Webinars, the Q&A allows for the audience to freely ask questions they may have difficulties to get answers to. And if we haven’t the time to address all questions during the live session, we have the opportunity to continue the discussion offline, which is a great advantage of such online platform.

4. Who or what inspired you to get into the industry? 

My background in Health and Safety when I worked for Boise State University as a program manager, in conjunction with OSHA. This experience really inspired me to get into the pharmaceutical and biopharmaceutical industries. Being able to protect operator’s lives has always been at the center of my inspiration.

5. What one item would you take with you to a desert island? 

My cell phone!! …. depending on cell coverage!

Michelle will be presenting Powder Systems Limited webinar ‘Cross over from Class III BCS to High Containment Isolators‘ on the 10th September. Register here.

Prof. Dr.-techn. Christoph Herwig, Professor for Biochemical Engineering, Vienna University of Technology

Leave a comment

Christoph HerwigChristoph Herwig, bioprocess engineer, graduated from the process engineering department, university of technology RWTH Aachen in 1994. He worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at the University of Technology EPFL, Lausanne Switzerland in the field of bioprocess identification. Subsequently he positioned himself at the interface between bioprocess development and facility design of biopharmaceutical facilities working in different companies from process development over engineering services to biopharmaceutical production. 

Since 2008, he has been a full professor for biochemical engineering at the Vienna University of Technology. The research area focuses on the development of method of science based and efficient bioprocess development for biopharmaceuticals along PAT and QbD principles in upstream and downstream within industry driven projects.

  1. You’ve mentioned that the development and control of biopharmaceutical processes is still a time extensive and complex task. Do you think it will always be like this?

Yes it is a complex task as the multivariate interactions between many parameters and quality attributes as well as key performance indicators need to elucidated. The first significant step for acceleration will be the provision of timely measurements of quality attributes, as they are as of now hardly available, the second one is going beyond trivial statistical regression to data science approaches.

  1. What do you most enjoy about your work?

Interdisciplinarity and motivated science oriented generation making use of the wealth of knowledge through combination of it.

  1. What do you hope people will take away from your webinar?

There are solutions to know about the quality attributes across the full process in a timely manner. The solution is a combination of  new measurement principle using monoliths and sound s data science approaches.

  1. What would someone be surprised to know about you?

Since I was 12 years old I have been a portrait photographer for magazines and newspapers. Also, I love riding on roller coasters with my daughters. I understand this as a unique privileged combination!

  1. Who or what inspired you to get into the industry?

As being currently in academia, the question should be why did I return from industry to academia! 1) academics must have experienced the real life being confronted with meeting timelines and costs to do successful research projects. 2) my motivation to return to academia, after having been 12 years in industry, was the conviction, that we can solve industrial challenges by generic methods, hence being a forefront multiplier for doing it right. 

Prof. Dr.-techn. Christoph Herwig will be presenting BIA Separations’ webinar ‘CQA impurity monitoring for integrated bioprocessing’ on the 17th September at 10am New York/3pm London. Read more and register here.

 

Graeme Fuller, Director CAP (Compressed Air and Process Filtration), Donaldson

Leave a comment

G

Graeme Fuller joined the company in 1986. In his current position as Director CAP EMEA he is responsible for all sales and service activities regarding Compressed Air and Process Filtration in Europe, Middle East and Africa.

 

 

1. What are you looking forward to discussing with the audience?

My colleagues Stefan Loebbert und Dr. Peter Schwarz will explain the recent developments of filtration devices in the Food & Beverage industry. This industry is governed by different regulatory organizations (e. g. FDA or EC regulations), confronting manufacturers, bottlers and plant managers with strict guidelines in respect of processing, purifying and protecting their goods. We help the F & B companies work within the guidelines that are given by offering tailor-made certified filtration solutions. These need to be not only reliable and of high-quality, but also strictly cost-effective. Besides dealing with the challenge of a fast-growing product range and the demands for high service quality while driving down operating costs, the F & B manufacturers seek filtration applications that meet the current FDA or EC regulations. You could say that these three areas of requirements distinguish F & B from other industries. And this is where Donaldson comes into play enabling F & B customers to achieve the right combination of market standards, cost pressure and legal compliance.

2. Why did you choose the F & B industry?

The F & B market is developing at high speed and continually evolving. It keeps constantly re-inventing itself, trying to satisfy emerging trends in the convenience product market, for example. A tough competition, shorter product life-cycles and a growing product variety obviously breed innovation, impacting the suppliers and their mind-set for innovation and creativity as well. In combination with a fierce regulatory framework, this leads to higher benchmarks for successful processing and filtration applications. Luckily Donaldson has built a strong team of engineers and researchers that have become very adaptive and know how to respond to the changing dynamics in the market.

3. Why did you decide to do a webinar?

As a multi-national corporation, we are very much involved into webcasts and web conferences. So inviting to a webinar appears as the next logical step, allowing us to connect with everyone around the world without having them to come to a certain place. And I think that a webinar gives more personal credibility to our ideas. As it brings people together sharing the same interests but exchanging different opinions, a webinar can broaden everyone’s horizon. So it is not only the audience that hopefully will take away our key messages, but also us that can learn from their feedback and real-time comments.

4. How do you motivate your team members?

We try to recruit self-motivated people with a good qualification. We then give them the freedom and the responsibility to develop their ideas and thus to contribute to the business success. Both, freedom and responsibility, help to be a motivated team member.

5. What motivates you?

Seeing our motivated team trying to achieve and to exceed the goals – this is what motivates me.

Join Donaldson’s webinar ‘Selection Criteria for Filtration Devices in Food & Beverage‘ on the 3rd September. Register here.

Dennis Curran, Product Management Director, BIOVIA

Leave a comment

dennisDennis Curran is the Director of Product Management for BIOVIA and is focused on the integration of BIOVIA Software into customer solutions for scientific research. His direct product responsibilities include the BIOVIA Workbook and BIOVIA Laboratory Operations Suite. Since receiving his degree in Analytical Chemistry from Tufts University in 1985, Mr. Curran has been involved in the laboratory automation and software industries. His 30 years of career experience spans the scientific, engineering, software and management aspects of projects in the life sciences industry, from Drug Discovery through Development and Quality Control operations.

1. What are you looking forward to discussing with the audience?

So many pharmaceutical and biopharmaceutical organizations are increasing their focus on biotherapeutic drug development in order to remain competitive in the market. Unfortunately, this can backfire when these organizations don’t take in to account the resources required for managing the additional complex data and processes involved. This can increase exposure to compliance risk, decrease overall productivity and extend the time to market for new products. I’m excited to have the opportunity to show the audience that there is a better way to not only manage, but leverage biologics data by eliminating inefficient paper-based workflows, reducing the effort for creating experiments, providing better understanding of processes and products, and much more.

2. You’ve mentioned that the biologics R&D workflow is similar to small molecule R&D at the highest level but that there are differences in the details. Can you explain what changes as an organization shifts toward biotherapeutic development?

In short, biologic development demands unique processes due to the added complexity of biological systems. Compared to small molecule R&D, biologics workflows generate a large amount and a large variety of complex data. However, being able to distill the information and track the genealogy of how to get to an end entity is critical. This requires some advanced data and workflow management.

3. Why do you feel this topic is important?

In a recent market survey we conducted, we asked responders what percentage of their biopharmaceutical development processes are being supported with manual methods like pen/paper and/or Excel spreadsheets. To our surprise (and concern), we found that almost half of the responses indicated that at least 75% of their biologic development processes were supported by manual methods. The industry clearly needs to see that an electronic solution is available and can manage the end-to-end biologics workflow without the risk or hindrance of manual work.

4. What do you hope the audience will learn from this webinar?

By attending this webinar, I hope the audience will see the true potential impact of transitioning from a paper-based to an electronic Biologics solution covering all activities of the development process end to end and how that positively affects their bottom line.

Dennis will be presenting BIOVIA’s webinar ‘Building Better Biologics, Faster‘ on the 22nd July. Register here.

Bob Holt, Biocatalysis Director, Piramal Healthcare

Leave a comment

Bob Holt 2

  • BSc in biochemistry from Bath University (1981)
  • PhD in metabolic control of the acetone/butanol fermentation from University of Wales (1984)
  • Post-doctoral research in biocatalysis at University of Wales (1984-88). 
  • Senior biocatalysis research scientist, ICI (1988-1993)
  • Biocatalysis R&D Manager, Zeneca Lifescience Molecules (1993-1999)
  • Biocatalysis Director, Avecia Pharmaceuticals (1999-2005)
  • Biocatalysis Director, Piramal Healthcare (2005-present)

1. Why did you decide to do a webinar with Business Review Webinars?

A webinar offers the opportunity to access a diverse, global audience in a way that is very efficient for both the presenter and the audience.

2. How did you get into the industry?

My interests in how biological systems function motivated my academic choices at university and stimulated my interest in enzyme catalysis.  It was a small step from there to imagine how the properties of Nature’s catalysts might be employed to perform interesting chemistry with non-natural compounds.  The opportunity to join Britain’s largest chemical company in 1988 provided an opportunity for me to apply my knowledge in an industrial setting and make a real contribution to the economy and society.

3. What do you most enjoy about your role?

The multi-disciplinary nature of industrial biocatalysis means interacting with scientists from a range of disciplines from microbiology and genetic engineering through synthetic and analytical chemistry through to process engineering and manufacturing; this provides endless stimulation and a continuing opportunity to interact with and learn from teams across the whole of the company.

4. What has been your best holiday and where would you recommend visiting?

Recommending a holiday destination is a dangerous thing as people have very different preferences but I enjoy getting away from the crowds and walking in the hills and mountains so that I can  enjoy the natural landscape.

5. What motivates you?

I am driven by a need to understand how things work but over-laid on that is a need to then do something useful with that knowledge; applying enzymes to solve difficult synthetic chemistry problems addresses both of these motivations.  I am also driven by a desire to share my knowledge of biology and chemistry with others both through lecturing at university but also amongst friends and family whose understanding of biology and chemistry is often extremely poor and adversely influenced by articles in the mainstream press.

Bob will be presenting Piramal Healthcare’s webinar ‘Doing Difficult Chemistry by Harnessing Biology‘ on the 16th July. Register here.

 

Antony Bourne, Global Industry Director, IFS

Leave a comment

Antony BourneAs the Global Industry Director at IFS, Antony’s responsibilities include acting as the Global Industry Director for Industrial Manufacturing and High Tech as well as managing the other global industry directors. Antony has over 15 years experience in the IT industry, including working in the manufacturing sector. Prior to joining IFS in 1997, he held Business Analyst positions with Ford Motor Company and AlliedSignal. During this time he implemented ERP applications as well as business process improvements.

1. What did the audience learn from attending the webinar?

They learnt that cost is not always the most important factor when choosing a new ERP package, functionality and usability are instead.

Another key factor is that flexibility of the solution ensures ROI.

2. What did you most enjoy about presenting to a live audience?

I always enjoy getting questions and feedback from the audience since it shows that they have understood the issues and want to learn more.

3. How did you get into the industry and what do you most enjoy about your role?

Started as a business analyst at an automotive supplier, installed a new ERP package when our plant was sold to another company, then was going to go to Ireland to be trained in a German ERP package, but had a call from IFS and have been there ever since (since 1997).

 4. What’s the best thing someone has ever taught you?

To always try my best, be honest, and don’t say that I know everything because I don’t and I never will. I am always learning new things from different companies on how they operate their business as well as embracing new technologies as they emerge in the market.

5. How are you hoping to help IFS to grow in the near future and what are your plans for 2015 and 2016?

By showing IFS Applications 9 to both existing customers and prospective customers, and by working with marketing and the analyst community to ensure that they are aware of what we can do and what makes us different to other ERP providers.

6. What motivates you?

I really enjoy meeting customers that I helped with during the sales process successfully going live and meeting up year after year. Listening them tell me that they are still happy with the solution and the support that they get from us makes me feel so happy.

Anthony presented along with his colleague Nick Castellina the IFS webinar ‘Select Flexible Enterprise Software and Be Prepared for Business Challenges’.

The session is now available to watch here.

 

Dr. Thomas P. Schoenknecht – Executive Director, Business Development. SHL Group

Leave a comment

Thomas P. SchoenknechtThomas Schoenknecht has over 20 years’ experience in the pharmaceutical industry in various leading roles such as project management, research & development and business development. Before joining SHL in 2013, Thomas was head of global Key Account Organization at Schott Pharmaceutical Packing Division with a specific focus on new product developments addressing customer needs. Prior to Schott, Thomas worked at Amgen Inc California as Director of Drug Product and Device Development, where he oversaw and managed Amgen’s global drug delivery container projects and interfaced Amgen’s drug delivery device platforms. Finally, previous to Amgen, Thomas headed up the Research & Development activities at Gerresheimer’s Pharmaceutical Packing Division and was leading the Product Management and Business Development activities of this division for sterile drug delivery solutions.

Thomas has a Ph.D. in Biophysical Chemistry from the Max-Planck-Society and the University Goettingen, Germany and a Master’s degree in Chemistry from the University Goettingen. He is a frequent speaker, moderator and committee member at conferences regarding drug delivery and packing material science; Thomas was heading the PDA interest group for prefilled syringes and being active as member in various DIN ISO committees regarding primary packaging materials and drug delivery devices.

Thomas Schönknecht is currently an Executive Director, Business Development at SHL Group, responsible for global Business Development, Key Account Management and new Technology Evaluation within SHL’s Medical division.

  1.      Why did you decide to do a webinar with us?

Webinars offer an excellent platform for an open interactive exchange with our business partners regarding important topics driving our industry. As such, you need to find a provider who can offer an advanced platform and should be seen among the leading webinar providers with an excellent reputation to offer presentation content of interest to our targeted audience. After thorough evaluation, we are very happy to be working with Business Review Webinars, who can provide a robust platform and has been able to help us reach our targeted audience.

  1.       What will the audience gain from attending your webinar?

Devices for drug delivery are becoming a more vital factor for the success of a new drug being launched to the market or later during life cycle management. To have a successful device development program some few basic prerequisites need to be fulfilled – such as the selection of the drug container, HF studies, and final packaging. This webinar will highlight the most important ones and provide insight through real case studies on how a device development program should be planned and executed.

  1.       Who or what inspired you to get into the industry?

My interest for the pharmaceutical industry was first fostered and later induced through scientific work on my masters and later my Ph.D. thesis, where I analyzed the molecular structure of biomolecules that can become a target for new medical applications or even a new lead structure which can be converted later on into a new therapeutic. Working at the forefront, identifying new therapeutics and later establishing robust drug delivery solutions for these new drug substances gives you a good feeling, as you are working in a field where you help to make the life of people a little bit better.

  1.       What’s the most useful thing someone has ever taught you?

I had the opportunity to learn how to do research and development during my masters and Ph.D. time in the lab of Manfred Eigen, a Nobel laureate in Chemistry. The most valuable thing I gained from my scientific work and from him, was self-reflection and how to analyze given issues or challenges from different perspectives, which enables me to  identify the optimal solution for a given task based on a complete understanding of the problem at hand.

5.      Where would you recommend visiting in the world and why?

For me as a person having lived on various places and on different continents, every new place I am going to for business or vacation does reveal its own magic and beauty if you are open minded and willing to explore it without prejudice. However, if you are interested in device technology in addition, I can clearly recommend to visit Taiwan and our headquarter in Taoyuan near Taipei.

Dr. Thomas P. Schoenknecht will be presenting in SHL Group’s webinar ‘Prerequisites for a successful drug delivery device development program‘ on the 17th June at 3pm London/10am New York. You can register for the webinar here.

Dr. Allan Jowsey PhD MEng CEng MIFireE MSFPE MASCE Fire Engineering Manager, AkzoNobel

Leave a comment

Allan JowseyDr. Jowsey obtained a PhD in Structural Fire Engineering from the University of Edinburgh in 2006.  He worked as a consultant Fire Engineer in London for several years and now leads a global team of Structural Engineers and Fire Engineers within AkzoNobel’s fire protection division.  Dr. Jowsey sits on numerous global technical committees and standards development bodies.  His work involves overseeing research and design activities while also generating practical solutions through liaisons with engineers, contractors and steelwork fabricators around the world on projects in the built environment and oil and gas markets.

1. Why did you decide to do a webinar with Business Review Webinars on fire design?

We speak to many designers and engineers across the contract chain about roles, responsibilities and possibilities when it comes to the fire resistance of structures.  We find that there is a thirst for knowledge in this area and a webinar provides a great platform to educate those in the industry to allow them to benefit and influence their individual projects.

2. What do you hope people will take away from your webinar on fire design?

Ideally people will appreciate that aspects of fire resistance and fire design warrant closer attention than merely adopting what is stated in a code or standard without fully understanding the basis of that decision.  The webinar will highlight that significant savings in weight and cost can be achieved while still adhering to the required levels of safety and robustness demanded by design.  Once designers understand the basis for a decision, it provides them with the ability and confidence to question its applicability.

3. What has been the highlight of your career?

Educating practicing engineers on fire resistance and providing them with the ability to start assessing structural performance of their buildings and assets in terms of enhanced and robust design checks in the event of a fire.

4. Where is your favorite place in the world and why?

On top of a hill or mountain anywhere in the world.  It’s a great escape that allows me to spend time with my family, to exercise and to think clearly.

Dr Allan Jowsey will be presenting alongside his colleague Robin Wade in AkzoNobel’s Webinar ‘Achieving weight savings through intelligent Fire Design’ on the 7th July at 3PM London/10AM New York. Register for the webinar here.